Lukas Roth

479 total citations
9 papers, 275 citations indexed

About

Lukas Roth is a scholar working on Immunology, Surgery and Dermatology. According to data from OpenAlex, Lukas Roth has authored 9 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Surgery and 3 papers in Dermatology. Recurrent topics in Lukas Roth's work include Colorectal and Anal Carcinomas (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Lukas Roth is often cited by papers focused on Colorectal and Anal Carcinomas (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Lukas Roth collaborates with scholars based in Switzerland, Germany and United States. Lukas Roth's co-authors include Frank Kolbinger, Grazyna Wieczorek, Iris C. Blijdorp, Sabina Pfister, Leonie M. van Duivenvoorde, Melissa N. van Tok, M. G. H. Van de Sande, Joel D. Taurog, Dominique Baeten and Ina Krämer and has published in prestigious journals such as Journal of Biological Chemistry, European Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

Lukas Roth

7 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Roth Switzerland 7 124 75 69 65 62 9 275
Hirotoshi Kawashima Japan 8 157 1.3× 56 0.7× 81 1.2× 8 0.1× 25 0.4× 16 304
Cornelis E. Hack Netherlands 7 148 1.2× 52 0.7× 51 0.7× 33 0.5× 9 0.1× 8 295
Florian Nagl Germany 5 52 0.4× 120 1.6× 13 0.2× 51 0.8× 103 1.7× 6 338
Jack Bevers United States 8 154 1.2× 93 1.2× 31 0.4× 80 1.2× 21 0.3× 12 352
Iris C. Blijdorp Netherlands 11 284 2.3× 66 0.9× 242 3.5× 39 0.6× 15 0.2× 18 399
P.A. Usher Denmark 6 303 2.4× 52 0.7× 45 0.7× 142 2.2× 6 0.1× 7 395
Muyao Guo China 8 160 1.3× 157 2.1× 25 0.4× 9 0.1× 20 0.3× 22 320
Jutta Schröder Germany 9 241 1.9× 64 0.9× 16 0.2× 38 0.6× 9 0.1× 10 342
Amanda M. Schmidt United States 9 290 2.3× 68 0.9× 21 0.3× 8 0.1× 14 0.2× 9 355
Winnie L. Kan Australia 5 129 1.0× 64 0.9× 26 0.4× 11 0.2× 15 0.2× 10 252

Countries citing papers authored by Lukas Roth

Since Specialization
Citations

This map shows the geographic impact of Lukas Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Roth more than expected).

Fields of papers citing papers by Lukas Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Roth. The network helps show where Lukas Roth may publish in the future.

Co-authorship network of co-authors of Lukas Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Roth. A scholar is included among the top collaborators of Lukas Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Roth. Lukas Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zierer, Jonas, Rik Osinga, Severin Läuchli, et al.. (2025). Hidradenitis Suppurativa Is an HLA-Associated Autoimmune Disease. Journal of Investigative Dermatology. 146(3). 840–843.e3.
3.
Kimball, Alexa B., Christian Loesche, Errol P. Prens, et al.. (2022). IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study. Experimental Dermatology. 31(10). 1522–1532. 32 indexed citations
4.
Penno, Carlos A., Andreas Hofmann, Dirk J. Schaefer, et al.. (2020). Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. Journal of Investigative Dermatology. 140(12). 2421–2432.e10. 40 indexed citations
5.
Tok, Melissa N. van, Leonie M. van Duivenvoorde, Ina Krämer, et al.. (2018). Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis. Arthritis & Rheumatology. 71(4). 612–625. 76 indexed citations
6.
Hermann‐Kleiter, Natascha, Marlies Meisel, Friedrich Fresser, et al.. (2012). Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter. Journal of Autoimmunity. 39(4). 428–440. 40 indexed citations
7.
Zerwes, Hans‐Günter, Jiří Kovařík, Markus Streiff, et al.. (2008). The Chemokine Receptor Cxcr3 Is Not Essential for Acute Cardiac Allograft Rejection in Mice and Rats. American Journal of Transplantation. 8(8). 1604–1613. 28 indexed citations
8.
Luckow, Bruno, Joanne Joergensen, Silvia Chilla, et al.. (2004). Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5‐deficient mice. European Journal of Immunology. 34(9). 2568–2578. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026